In the August 8 issue, Dr. Louise Mullan, a member-in-training Assembly representative, protested how the Appelbaum work group report and recommendations on "ethics guidelines regarding the relationships of psychiatrists with the pharmaceutical industry" (recommendations similar to those of the Institute of Medicine, Association of American Medical Colleges, Council of Medical Specialty Societies, and proposed guidelines sent by AMA to its Council on Ethical and Judicial Affairs) should have been discussed, debated, and negotiated in an open plenary session at last May's Assembly meeting but was sent to a reference committee where it "died" and where "attempts to have a discussion thereafter were stymied."